Fragment-based Drug Discovery - Global Market Trajectory & Analytics

DESCRIPTION
TABLE OF CONTENTS

1 of 2

Global Fragment-based Drug Discovery Market to Reach $1.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Fragment-based Drug Discovery estimated at US$568 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 10.4% over the period 2020-2027. Fragment Screening Technique, one of the segments analyzed in the report, is projected to record 11% CAGR and reach US$644.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fragment Optimization Technique segment is readjusted to a revised 9.7% CAGR for the next 7-year period.

The U. S. Market is Estimated at $168.6 Million, While China is Forecast to Grow at 9.7% CAGR

The Fragment-based Drug Discovery market in the U. S. is estimated at US$168.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$195.6 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR. We bring years of research experience to this 9th edition of our report. The 176-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

Astex Pharmaceuticals, Inc.
Beactica AB
Charles River Laboratories International, Inc.
Evotec AG
Sygnature Discovery Ltd.

Note: Product cover images may vary from those shown

2 of 2

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares
Fragment-based Drug Discovery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: World Current & Future Analysis for Fragment-based Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 2: World Historic Review for Fragment-based Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 3: World 15-Year Perspective for Fragment-based Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Fragment Screening Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 5: World Historic Review for Fragment Screening Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 6: World 15-Year Perspective for Fragment Screening Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Fragment Optimization Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 8: World Historic Review for Fragment Optimization Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 9: World 15-Year Perspective for Fragment Optimization Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 11: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 12: World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 14: World Historic Review for Contract Research Organization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 15: World 15-Year Perspective for Contract Research Organization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Academic and Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 17: World Historic Review for Academic and Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 18: World 15-Year Perspective for Academic and Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures
US Fragment-based Drug Discovery Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 19: USA Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 20: USA Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 21: USA 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 22: USA Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 23: USA Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 24: USA 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

CANADA

TABLE 25: Canada Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 26: Canada Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 27: Canada 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 28: Canada Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 29: Canada Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 30: Canada 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

JAPAN

TABLE 31: Japan Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 32: Japan Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 33: Japan 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 34: Japan Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 35: Japan Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 36: Japan 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

CHINA

TABLE 37: China Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 38: China Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 39: China 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 40: China Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 41: China Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 42: China 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

EUROPE

Market Facts & Figures
European Fragment-based Drug Discovery Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 43: Europe Current & Future Analysis for Fragment-based Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
TABLE 44: Europe Historic Review for Fragment-based Drug Discovery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 45: Europe 15-Year Perspective for Fragment-based Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 46: Europe Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 47: Europe Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 48: Europe 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 49: Europe Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 50: Europe Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 51: Europe 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

FRANCE

TABLE 52: France Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 53: France Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 54: France 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 55: France Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 56: France Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 57: France 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

GERMANY

TABLE 58: Germany Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 59: Germany Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 60: Germany 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 61: Germany Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 62: Germany Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 63: Germany 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

ITALY

TABLE 64: Italy Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 65: Italy Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 66: Italy 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 67: Italy Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 68: Italy Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 69: Italy 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

UNITED KINGDOM

TABLE 70: UK Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 71: UK Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 72: UK 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 73: UK Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 74: UK Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 75: UK 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

REST OF EUROPE

TABLE 76: Rest of Europe Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 77: Rest of Europe Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 78: Rest of Europe 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 79: Rest of Europe Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 80: Rest of Europe Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 81: Rest of Europe 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

ASIA-PACIFIC

TABLE 82: Asia-Pacific Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 83: Asia-Pacific Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 84: Asia-Pacific 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 85: Asia-Pacific Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 86: Asia-Pacific Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 87: Asia-Pacific 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

REST OF WORLD

TABLE 88: Rest of World Current & Future Analysis for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 89: Rest of World Historic Review for Fragment-based Drug Discovery by Service Type - Fragment Screening Technique and Fragment Optimization Technique Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 90: Rest of World 15-Year Perspective for Fragment-based Drug Discovery by Service Type - Percentage Breakdown of Value Sales for Fragment Screening Technique and Fragment Optimization Technique for the Years 2012, 2020 & 2027
TABLE 91: Rest of World Current & Future Analysis for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
TABLE 92: Rest of World Historic Review for Fragment-based Drug Discovery by End-Use - Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
TABLE 93: Rest of World 15-Year Perspective for Fragment-based Drug Discovery by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Research Organization and Academic and Research Institutions for the Years 2012, 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 44

Note: Product cover images may vary from those shown

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one specific user access to the product.	€4355EUR$4,950USD£3,967GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€8275EUR$9,405USD£7,537GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€13066EUR$14,850USD£11,900GBP

RELATED TAGS

RELATED PRODUCTS

Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030

Modern Approaches in Drug Discovery, Vol 610. Methods in Enzymology

Applied Biophysics for Drug Discovery

Platform Technologies in Drug Discovery and Validation, Vol 50. Annual Reports in Medicinal Chemistry

Basic Principles of Drug Discovery and Development. Edition No. 2